(This post originally appeared on Forbes on 6/19/17)
A plant biotechnology company called 22ND Century (NASDAQ: XXII) is developing two very interesting new crop varieties. One is a line of tobacco that barely makes any nicotine. The idea is to use that tobacco to make cigarettes that can help people quit smoking. 22ND Century’s other new offering is a line of marijuana that doesn’t make THC. The goal in this case is to make it possible for people to realize various medical benefits of Cannabis without the physical and legal complications of the high. Both of these offerings demonstrate how the increasingly sophisticated scientific understanding of plant genetics can lead to positive contributions.
|How smoking varies around the world
A zero-THC product could help not only with uses where the “high” is undesirable, but it will also make this kind of relief more practical by clearly separating the medical and recreational uses of this plant.